Order of Radiation Sickness Drug Unrelated to Recent Events in Ukraine, U.S. Health Officials Say
MONDAY, Oct. 10, 2022 (HealthDay News) – While the United States has recently ordered a $290 million supply of a drug meant to treat radiation sickness, federal health officials say that’s not cause for alarm. It’s coincidental that the order of Nplate, made by pharmaceutical company Amgen, comes just asContinue Reading